The management of motor neurone disease

J Neurol Neurosurg Psychiatry. 2003 Dec;74 Suppl 4(Suppl 4):iv32-iv47. doi: 10.1136/jnnp.74.suppl_4.iv32.

Authors

P N Leigh¹, S Abrahams, A Al-Chalabi, M-A Ampong, L H Goldstein, J Johnson, R Lyall, J Moxham, N Mustfa, A Rio, C Shaw, E Willey; King's MND Care and Research Team

Affiliation

¹ The King's MND Care and Research Centre, Institute of Psychiatry, Guy's King's and St Thomas's School of Medicine, and King's College Hospital, London, UK. n.leigh@iop.kcl.ac.uk

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Gastrostomy
Genetic Counseling
Humans
Motor Neuron Disease / complications
Motor Neuron Disease / diagnosis*
Motor Neuron Disease / therapy*
Neuroprotective Agents / therapeutic use
Respiration, Artificial
Riluzole / therapeutic use
Terminal Care

Substances

Neuroprotective Agents
Riluzole